SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

8 marketing jobs

Integra LifeSciences logo
8 days ago

Senior Regional Product Marketing Manager

Integra LifeSciences

Princeton, NJ (Unknown)Full time$125K/yr – $173K/yr
Integra LifeSciences logo
9 days ago

Senior Regional Product Marketing Manager

Integra LifeSciences

Mansfield, MA (On-site)Full time$125K/yr – $173K/yr
Integra LifeSciences logo
2 weeks ago

Director, US Regional Marketing ENT & Instruments

Integra LifeSciences

Irvine, CA (On-site)Full time$167K/yr – $229K/yr
Integra LifeSciences logo
1 month ago

Director, US Regional Marketing ENT & Instruments

Integra LifeSciences

Princeton, NJ (Unknown)Full time$167K/yr – $229K/yr
Integra LifeSciences logo
2 months ago

Senior Regional Product Marketing Manager

Integra LifeSciences

USA (Remote)Full time$109K/yr – $150K/yr
Integra LifeSciences logo
3 months ago

Senior Global Product Marketing Manager

Integra LifeSciences

Princeton, NJ (Unknown)Full time$125K/yr – $173K/yr
Integra LifeSciences logo
3 months ago

Senior Global Product Marketing Manager

Integra LifeSciences

Princeton, NJ (On-site)Full time$125K/yr – $173K/yr
Integra LifeSciences logo
5 months ago

Senior Manager, Regional Product Marketing

Integra LifeSciences

Princeton, NJ (On-site)Full time$125K/yr – $173K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

8 jobs
Integra LifeSciences logo

Senior Regional Product Marketing Manager

Integra LifeSciences

Princeton, NJ (Unknown)

$125K/yr - $173K/yrIn-houseFull-timeSenior level12+ years exp.
8 days ago
Integra LifeSciences logo

Senior Regional Product Marketing Manager

Integra LifeSciences

Mansfield, MA (On-site)

$125K/yr - $173K/yrIn-houseFull-timeSenior level8+ years exp.
9 days ago
Integra LifeSciences logo

Director, US Regional Marketing ENT & Instruments

Integra LifeSciences

Irvine, CA (On-site)

$167K/yr - $229K/yrIn-houseFull-timeDirector/executive15+ years exp.
2 weeks ago
Integra LifeSciences logo

Director, US Regional Marketing ENT & Instruments

Integra LifeSciences

Princeton, NJ (Unknown)

$167K/yr - $229K/yrIn-houseFull-timeDirector/executive15+ years exp.
1 month ago
Integra LifeSciences logo

Senior Regional Product Marketing Manager

Integra LifeSciences

USA (Remote)

$109K/yr - $150K/yrIn-houseFull-timeSenior level5+ years exp.
2 months ago
Integra LifeSciences logo

Senior Global Product Marketing Manager

Integra LifeSciences

Princeton, NJ (Unknown)

$125K/yr - $173K/yrIn-houseFull-timeSenior level8+ years exp.
3 months ago
Integra LifeSciences logo

Senior Global Product Marketing Manager

Integra LifeSciences

Princeton, NJ (On-site)

$125K/yr - $173K/yrIn-houseFull-timeSenior level12+ years exp.
3 months ago
Integra LifeSciences logo

Senior Manager, Regional Product Marketing

Integra LifeSciences

Princeton, NJ (On-site)

$125K/yr - $173K/yrIn-houseFull-timeSenior level
5 months ago
Integra LifeSciences logo
Integra LifeSciences

Senior Regional Product Marketing Manager

Princeton, NJ (Unknown)

$125K/yr – $173K/yrSenior Level12+ years expFull time

Posted 8 days ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Owns end-to-end product marketing for NCC and MIS Neurosurgery, leading strategic planning, NPI execution, and cross-functional collaboration to drive demand and revenue.

  • Lead development of marketing plans and launches to align with sales strategy
  • Coordinate cross-functional efforts including SAC, education programs, and clinician-facing assets

Job Description

Responsibilities

  • Leads development of product marketing plans by preparing objectives, strategies, tactics, profit and loss projections, including short and long-term strategies. Participate in strategic sales and marketing planning activities for effective customer segmentation, targeting, and promotion.
  • Develops and implements product marketing deliverables including claims matrices, competitive analysis, launch planning, promotional assets (web, social media, brochures, etc.). Work with Marketing Communications and other departments to ensure products are properly positioned.
  • Own all downstream New Product Introduction (NPI) planning and execution including positioning collateral, social media or digital promotion, field communication, performance metric collection, and forecasting. Work effectively with the Sales Advisory Council (SAC) to ensure deliverables are high quality and pertinent to their needs.
  • Collaborate with professional education and medical affairs to enhance existing product marketing activities (surgeon education programs, white papers, testimonials, clinical study summaries, etc.).
  • Collaborate with Field Personnel to participate in effective surgeon/key account field visits, enhance Customer Relationship Management, and maintain engagement where needed.
  • Work with critical internal stakeholders including those in Regulatory, Legal, Medical Affairs, and Product development to ensure assets comply while expediting the copy approval process before releasing to key internal and external customers.
  • Build revenue forecasting for all product lines in the NCC and MIS Neurosurgery product lines. This includes updating demand forecasting to ensure Supply & Operational Planning is accurate and maximizes net revenue targets. Monitor forecasts as necessary and work collaboratively with other departments to ensure product availability throughout the product lifecycle
  • Maintain frequent and regular contact with strategic industry experts, trade organizations and scientific societies; participates in key meetings and conferences to ensure company and products are perceived superior relative to the competition
  • Support the Company’s medical education initiative by assisting in the preparation and running of surgeon training courses when needed.

Requirements

  • Bachelor’s degree or equivalent with 12+ years of total work experience; master’s degree/MBA preferred; 8+ years' experience in marketing and/or commercial functions within medical device or healthcare-related fields is required.
  • Excellent conceptual problem-solving skills, with demonstrated ability to bring structure and process to vaguely defined problems is required.
  • Operating Room or Neuro Intensive Care product technology experience strongly preferred
  • Strong project management, written communications, verbal, and presentation skills are required.
  • Must be highly collaborative, with a proven ability to lead, operate and influence cross-functionally and to influence without authority.
  • Demonstrated problem-solving skills with ability to structure a problem-solving approach and manage execution required
  • Travel requirement approximately 25%

Preferred

  • Data Analysis / AI fluency: Demonstrated capability in using Co-Pilot / AI tools when assessing or analyzing data for decision making.

Benefits

  • medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance, and savings plan (401(k)).
Integra LifeSciences logo

Integra LifeSciences

2.9 Glassdoor

Integra LifeSciences is a global medical technology leader dedicated to restoring lives. Headquartered in Princeton, New Jersey, we are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated gold-standard products and solutions is built on decades of clinical evidence and trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and our products, visit www.integralife.com.

Founded in 1989
Princeton, New Jersey, USA
3.9K employees (69 in marketing)
www.integralife.com
36% recommend to a friend
46% CEO approval

Salaries

Posted range

$125K/yr – $173K/yr

Taken straight from the job posting.

See all Integra LifeSciences salaries

Marketing Team

Marketing Team Size
69 (2% of company)
Median Tenure
9 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$350M
Last Raise
$350M
Post IPO Equity, 8 years ago

Funding History

  • May 2018
    Post IPO Equity • $350M

Traffic Signals

Monthly Visitors
116.5K
Traffic Source Mix
Search
58.4%
Direct
33.4%
Referral
6.2%
Social
1.2%
Paid
0.7%

Headcount Trend

Current headcount: ~3.9K

Recent News

Why Integra LifeSciences Holdings Corporation stock is recommended by analysts - Earnings Summary Report & Weekly Stock Performance Updates
Nov 21, 2025 • newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond market - July 2025 EndofMonth & Fast Entry High Yield Stock Tips
Nov 19, 2025 • newser.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock - 2025 Year in Review & Risk Controlled Swing Trade Alerts
Nov 19, 2025 • newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation - Weekly Trade Analysis & Reliable Volume Spike Trade Alerts
Nov 19, 2025 • newser.com
Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART)
Nov 17, 2025 • TradingView
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stock - Trade Risk Report & Detailed Earnings Play Alerts
Nov 16, 2025 • newser.com
Integra LifeSciences (IART) Stock Trades Up, Here Is Why
Nov 13, 2025 • Yahoo Finance
Integra wins FDA nod for ultrasonic surgical aspiratory system for cardiac surgeries
Nov 12, 2025 • MassDevice
Integra LifeSciences Receives FDA 510(k) Clearance for Use
Nov 11, 2025 • GlobeNewswire
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device
Nov 11, 2025 • investing.com
Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator in Cardiac Surgery Applications
Nov 11, 2025 • Quiver Quantitative
Integra LifeSciences Holdings Corporation stock trend forecast - July 2025 Selloffs & Precise Swing Trade Alerts
Nov 10, 2025 • newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stock - 2025 Historical Comparison & Weekly Watchlist for Hot Stocks
Nov 10, 2025 • newser.com
5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call
Nov 5, 2025 • Yahoo Finance
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Nov 3, 2025 • TradingView
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Nov 3, 2025 • Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2025 Earnings Call Transcript
Nov 1, 2025 • Insider Monkey
Integra LifeSciences (IART): Deep Losses and Discounted Valuation Shape Sentiment Ahead of Earnings
Nov 1, 2025 • Yahoo Finance
Integra LifeSciences Earnings Call: Mixed Sentiment and Strategic Advancements
Oct 31, 2025 • TipRanks
Citigroup Maintains "Sell" Rating on Integra Lifesciences (IART) with Lowered Price Target | IART Stock News
Oct 31, 2025 • GuruFocus
Integra LifeSciences Drops After Cutting Revenue Outlook
Oct 31, 2025 • Finimize
Strong Q3 Can't Shake Integra's Struggles: Shares Hit All-Time Low Despite Earnings Beat
Oct 30, 2025 • Medical Device and Diagnostic industry
Integra LifeSciences Reports Strong Q3 2025 Results
Oct 30, 2025 • TipRanks
Integra LifeSciences stock hits 52-week low at 11.05 USD
Oct 30, 2025 • investing.com
Integra LifeSciences Q3 Loss Narrows; Cuts FY25 Revenue Guidance; Stock Up
Oct 30, 2025 • Nasdaq
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ...
Oct 30, 2025 • Yahoo Finance
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q3 2025 Result
Oct 29, 2025 • Yahoo Finance
Integra LifeSciences Advances with MIRROR Registry Study on Hematoma Evacuation
Oct 27, 2025 • TipRanks
Intraday pattern recognizer results for Integra LifeSciences Holdings Corporation - Portfolio Return Report & Free Accurate Trade Setup Notifications
Oct 23, 2025 • newser.com
Will Integra LifeSciences Holdings Corporation (IL3) stock gain from lower interest rates - Trade Risk Report & Risk Controlled Daily Plans
Oct 23, 2025 • newser.com
Is Integra LifeSciences Holdings Corporation stock undervalued vs historical averages - 2025 Fundamental Recap & Expert Curated Trade Setup Alerts
Oct 23, 2025 • newser.com
Is Integra LifeSciences Holdings Corporation stock undervalued vs historical averages - July 2025 Trends & Smart Money Movement Tracker
Oct 23, 2025 • nchmf.gov.vn
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock - Market Performance Summary & AI Forecasted Entry and Exit Points
Oct 23, 2025 • newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growth - Short Setup & Smart Money Movement Alerts
Oct 23, 2025 • newser.com
Integra LifeSciences (IART) Is Up 8.7% After Strategic Moves Spotlight Recovery Hopes—Has The Bull Case Changed?
Oct 23, 2025 • simplywall.st
Intraday pattern recognizer results for Integra LifeSciences Holdings Corporation - Weekly Trend Summary & Low Risk Entry Point Guides
Oct 22, 2025 • newser.com
Forecasting Integra LifeSciences Holdings Corporation price range with options data - Weekly Stock Recap & Expert Verified Stock Movement Alerts
Oct 20, 2025 • newser.com
Is Integra LifeSciences (IART) Undervalued? A Fresh Look at Recent Valuation Debate
Oct 20, 2025 • simplywall.st
How Integra LifeSciences Holdings Corporation (IL3) stock trades in high volatility - July 2025 Earnings & Capital Efficiency Focused Ideas
Oct 20, 2025 • newser.com
What Recent FDA Clearance Means for Integra LifeSciences Holdings Stock Valuation
Oct 20, 2025 • Yahoo Finance
Does Integra LifeSciences Holdings Corporation qualify in momentum factor screening - July 2025 News Drivers & Technical Analysis for Trade Confirmation
Oct 20, 2025 • newser.com
Integra LifeSciences Holdings (IART): Examining Valuation After Recent Share Price Rebound
Oct 20, 2025 • Yahoo Finance
Does Integra LifeSciences Share Rebound Signal a New Growth Phase in 2025?
Oct 18, 2025 • simplywall.st
Does Integra LifeSciences Share Rebound Signal a New Growth Phase in 2025?
Oct 18, 2025 • Sahm
Is Integra LifeSciences Holdings Corporation (IL3) stock safe for risk averse investors - 2025 Analyst Calls & Fast Gaining Stock Reports
Oct 18, 2025 • nchmf.gov.vn
Why Integra LifeSciences Holdings Corporation stock could see breakout soon - July 2025 Snapshot & Entry Point Confirmation Signals
Oct 18, 2025 • nchmf.gov.vn
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Oct 15, 2025 • GlobeNewswire
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Oct 15, 2025 • Sahm
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Oct 15, 2025 • Yahoo Finance
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Oct 15, 2025 • TradingView
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
Oct 8, 2025 • Yahoo Finance
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
Oct 8, 2025 • GlobeNewswire
Integra LifeSciences (IART): Assessing Current Valuation After a Recent Share Price Dip
Oct 3, 2025 • Yahoo Finance
United States Wound Care Market Report 2025-2033: Key States Like California, Texas, New York, and Florida Highlight Diverse Regional Growth Driven by Demand for Advanced Wound Management Solutions
Sep 26, 2025 • Research and Markets
Craniomaxillofacial Devices Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034
Sep 25, 2025 • Research and Markets
Neurosurgeon with 150+ Publications: Integra LifeSciences Taps Dr. Raymond Turner as New Chief Medical Officer
Sep 22, 2025 • Stock Titan
Integra LifeSciences appoints Raymond Turner as CMO
Sep 22, 2025 • thefly.com
Integra LifeSciences Appoints Dr. Raymond Turner as Vice President and Chief Medical Officer
Sep 22, 2025 • citybiz
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
Sep 22, 2025 • Integra LifeSciences Holdings Corporation
Neuroregeneration Therapy Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Sep 12, 2025 • EIN Presswire
Integra LifeSciences Still Recovering From Self-Inflicted Wounds (NASDAQ:IART)
Sep 10, 2025 • Seeking Alpha
Integra LifeSciences at Morgan Stanley Conference: Strategic Growth Amid Challenges
Sep 10, 2025 • investing.com
Abdominal Core Health Quality Collaborative Registry Surpasses 150,000 Patients
Sep 2, 2025 • PRWeb
Medical Tech Leader Integra LifeSciences Sets Dual Conference Appearances in September 2025
Aug 29, 2025 • Stock Titan
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Aug 29, 2025 • Yahoo Finance
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Aug 29, 2025 • Integra LifeSciences Holdings Corporation
Nerve Conduit Market Analysis: Emerging Opportunities and Strategic Insights
Aug 27, 2025 • PharmiWeb
Surgical Mesh Implants Market to Exceed US $5.13 Billion by 2029, with 0% CAGR: The Business Research Company
Aug 22, 2025 • EIN Presswire
Neurointerventional Devices Market is Projected to Increase at a CAGR of 7.2% Through 2025-2029
Aug 22, 2025 • EIN Presswire
Orthobiologics Market to Reach USD 12.2 Billion by 2035, Driven by Rising Demand for Regenerative Therapies
Aug 22, 2025 • EIN Presswire
Stereotactic Neuro-Navigation System Market Analysis Report 2025-2035 | Medtronic, Brainlab, Stryker, and Orthofix Lead the $840.7 Million Market - ResearchAndMarkets.com
Aug 20, 2025 • Business Wire
Hydrogel Dressing Market Poised for Transformative Growth with Rising Demand in Advanced Wound Care Solutions 2025
Aug 20, 2025 • EIN Presswire
Wound Gel Market Size to Exceed USD 9.09 Billion by 2032, Driven by Growing Geriatric Population | SNS Insider
Aug 19, 2025 • SNS Insider pvt ltd
Do-it-yourself founder built Gentell into a global wound-care maker
Aug 18, 2025 • The Philadelphia Inquirer
Spinal Cord Stimulation Device Market Set to Reach USD 7.5 Billion by 2035, Growing at a CAGR of 6.35%
Aug 14, 2025 • EIN Presswire
Wound Care Management Devices Market Poised to Growth USD 30.0 Billion by 2035 with Thriving CAGR of 4.21%
Aug 13, 2025 • EIN Presswire
Integra Life Q2: Sales Flat, Losses Titanic, Master Plan Marches On
Aug 12, 2025 • Orthopedics This Week
Intracranial Aneurysm Market to Hit $2.7 Billion by 2031, Driven by Rising Demand for Minimally Invasive Solutions
Aug 11, 2025 • EIN Presswire
Stereotactic Neuro-Navigation System Market Analysis Report 2025-2035 | Partnerships and Innovations Drive Progress in Technologies, Spinal Applications Lead Amid Rise in Spinal Disorders
Aug 11, 2025 • Research and Markets
Joint Reconstruction Device Market Projected to Reach 33.69 USD Billion, with a Robust 3.92% CAGR Till 2034
Aug 8, 2025 • EIN Presswire
Brain Computer Interface Market to Soar from USD 1.6 Billion in 2024 to USD 6.3 Billion by 2033, at 20.5% CAGR - Market Research Intellect
Aug 7, 2025 • PR Newswire
Brain Computer Interface Market to Soar from USD 1.6 Billion in 2024 to USD 6.3 Billion by 2033, at 20.5% CAGR - Market Research Intellect
Aug 7, 2025 • PR Newswire UK
Surgical Equipment Market: Global Insights, Trends, and North American Focus
Aug 6, 2025 • PharmiWeb
Microsurgery Market to Reach USD 3.80 Billion by 2032, Driven by Advancements in Reconstructive and Neurological Procedures - SNS Insider
Aug 5, 2025 • SNS Insider pvt ltd
Pressure Ulcers Treatment Market Report 2025-2034: Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape
Aug 4, 2025 • Research and Markets
Shoulder Arthroplasty Market to Hit $2.7B by 2035, Driven by Innovation from Key Players like Zimmer Biomet & Stryker
Aug 1, 2025 • EIN Presswire
Integra LifeSciences Reports Second Quarter 2025 Financial Results
Jul 31, 2025 • GlobeNewswire
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets
Jul 31, 2025 • Yahoo Finance
Integra LifeSciences Reports Q2 2025 Financial Results
Jul 31, 2025 • TipRanks
Integra LifeSciences Reports Second Quarter 2025 Financial Results
Jul 31, 2025 • BioSpace
Integra LifeSciences reports Q2 adjusted EPS 45c, consensus 43c
Jul 31, 2025 • thefly.com
Integra LifeSciences Q2 non-GAAP Earnings, Revenue Fall
Jul 31, 2025 • MarketScreener
Integra LifeSciences backs FY25 adjusted EPS view $2.19-$2.29, consensus $2.24
Jul 31, 2025 • thefly.com
Biosurgery Market is expected to generate a revenue of USD 25.64 Billion by 2031, Globally, at 6.4% CAGR: Verified Market Research®
Jul 31, 2025 • PR Newswire UK
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result
Jul 30, 2025 • Yahoo Finance
Regenerative Medicine Scaffolds Market Poised for Rapid Rise: Forecast to Reach USD 1.72 Billion by 2032
Jul 28, 2025 • PharmiWeb
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott
Jul 25, 2025 • Research and Markets
Skull Clamps Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Technological Advancements with FDA Approval of DORO LUCENT, Led by Key Players Like Integra and Mizuho OSI
Jul 25, 2025 • Research and Markets
Hip Replacement Market is projected to reach $8.6 billion by 2031 | Global Strategic Business Report
Jul 24, 2025 • EIN Presswire
Understanding The Growth Of The Hip Replacement Industry By 2035
Jul 22, 2025 • PharmiWeb

Links

www.integralife.comLinkedInX (Twitter)Crunchbase